百奥泰：产品取得注册证

每日经济新闻04-03

每经AI快讯，百奥泰（SH 688177，收盘价：35.03元）4月3日晚间发布公告称，百奥泰生物制药股份有限公司于近日收到国家药品监督管理局核准签发的关于托珠单抗注射液的《药品注册证书》。该药品获批新规格：200mg/10mL。产品名称为“托珠单抗注射液”。2023年1至12月份，百奥泰的营业收入构成为：医药制造占比100.0%。百奥泰的总经理、董事长均是LI SHENGFENG(李胜峰)，男，...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2424896311?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-04-03 16:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2424896311","market":"sh","top_or_hot":-1,"title":"百奥泰：产品取得注册证","media":"每日经济新闻","content":"<div>\n<p>每经AI快讯，百奥泰（SH 688177，收盘价：35.03元）4月3日晚间发布公告称，百奥泰生物制药股份有限公司于近日收到国家药品监督管理局核准签发的关于托珠单抗注射液的《药品注册证书》。该药品获批新规格：200mg/10mL。产品名称为“托珠单抗注射液”。2023年1至12月份，百奥泰的营业收入构成为：医药制造占比100.0%。百奥泰的总经理、董事长均是LI SHENGFENG(李胜峰)，男，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>百奥泰：产品取得注册证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n百奥泰：产品取得注册证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-03 16:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>每经AI快讯，百奥泰（SH 688177，收盘价：35.03元）4月3日晚间发布公告称，百奥泰生物制药股份有限公司于近日收到国家药品监督管理局核准签发的关于托珠单抗注射液的《药品注册证书》。该药品获批新规格：200mg/10mL。产品名称为“托珠单抗注射液”。2023年1至12月份，百奥泰的营业收入构成为：医药制造占比100.0%。百奥泰的总经理、董事长均是LI SHENGFENG(李胜峰)，男，...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b","article_id":"2424896311","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040317021587d9f242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2424896311","pubTimestamp":1712133895,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"每经AI快讯，百奥泰 4月3日晚间发布公告称，百奥泰生物制药股份有限公司于近日收到国家药品监督管理局核准签发的关于托珠单抗注射液的《药品注册证书》。产品名称为“托珠单抗注射液”。2023年1至12月份，百奥泰的营业收入构成为：医药制造占比100.0%。百奥泰的总经理、董事长均是LI SHENGFENG(李胜峰)，男，65岁，学历背景为博士。截至发稿，百奥泰市值为145亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688177":"百奥泰","BK0239":"医药制造"},"translate_title":"Baiaotai: The product has obtained the registration certificate","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688177":0.9},"content_text":"每经AI快讯，百奥泰（SH 688177，收盘价：35.03元）4月3日晚间发布公告称，百奥泰生物制药股份有限公司于近日收到国家药品监督管理局核准签发的关于托珠单抗注射液的《药品注册证书》。该药品获批新规格：200mg/10mL。产品名称为“托珠单抗注射液”。2023年1至12月份，百奥泰的营业收入构成为：医药制造占比100.0%。百奥泰的总经理、董事长均是LI SHENGFENG(李胜峰)，男，65岁，学历背景为博士。截至发稿，百奥泰市值为145亿元。道达号（daoda1997）“个股趋势”提醒：1. 百奥泰近30日内北向资金持股量减少32.26万股，占流通股比例减少0.07%；2. 近30日内共有1批机构对百奥泰调研，合计调研的机构家数为71家。每经头条（nbdtoutiao）——3年亏损约50％，明星基金经理跌落神坛，不再“看人买基”，基民该如何选择？(记者 王瀚黎)","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424896311"}